Skip to content

Health Promotion and Management for Hepatitis B Carriers

Project of Health Promotion and Management for Hepatitis B Carriers in NTU Campus

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01065363
Enrollment
160
Registered
2010-02-09
Start date
2009-08-31
Completion date
2010-12-31
Last updated
2010-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Hepatitis B

Keywords

Hepatitis B virus DNA, Metabolic factor, Body mass index, Obesity, Insulin resistance, Lifestyle factor, Preventive Medicine, Health Promotion

Brief summary

The investigators propose a project of preventive medicine with concern of local context in Taiwan. The target population includes all staff and faculty members, students, and alumni of a university in Northern Taiwan, with chronic hepatitis B infection. The intervention of this project includes standardized lectures, sports courses, nutrition courses, and an information platform. The investigators will evaluate the efficacy after the intervention, like the reduction of hepatitis B viral load and the associated anthropometric parameters. The results of this project will be initially served as a pilot study for this cohort, and applicated as a promising basis for health promotion.

Interventions

BEHAVIORALstandardized exercise program and dietary counseling

Lecture, 12 weeks Standardized exercise program, 12 weeks Dietary counseling, 12 weeks Information platform, 12 weeks

Sponsors

National Taiwan University
CollaboratorOTHER
National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants were recruited from students, alumni, faculty and staff members with chronic HBV infection (positive HBsAg serostatus ≥6 months) in a university of northern Taiwan from August 1, 2009 to July 01, 2010. Only participants aged 18 and older were included.

Exclusion criteria

* Excluded were: * (a) those who had been diagnosed as chronic liver diseases like chronic hepatitis C infection (Anti-HCV (+)), autoimmune hepatitis, Wilson disease, alcoholic liver diseases, drug-related hepatitis, decompensated liver diseases, cirrhosis, or malignant hepatic tumors; * (b) those who had undergone liver transplantation or major operations for liver except cholecystectomy; * (c) men who consumed more than 30 gram of alcohol per week or women who consumed more than 20 gram of alcohol per week; * (d) women who were pregnant; * (e) those who had current medications for any types of chronic diseases except for hyperglycemia, elevated blood pressure, or dyslipidemia within six months.

Design outcomes

Primary

MeasureTime frame
Reduction of relative serum HBV DNA levelsthree months

Secondary

MeasureTime frame
anthropometric indexthree months

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026